Akash PasrichainWest DoseA Conversation with David Bronner, the CEO of a Soap Company Funding Psychedelics’ Drug ReformDavid Bronner’s company collected $190 million in sales in 2020. But he rarely talks about that. Bronner, the CEO (Cosmic Engagement…Apr 1, 2021Apr 1, 2021
Akash PasrichainWest DoseOregon Governor Appoints Board to Advise on Psilocybin Services Roll OutOregon Gov. Kate Brown announced members who will serve on the state’s Psilocybin Advisory Board on Tuesday. The board is a diverse group…Mar 17, 2021Mar 17, 2021
Akash PasrichainWest DoseWill Oregon’s Psilocybin Program Solve the Racial Inequities that Cannabis Did Not?Her doctor recommended she try a course of antidepressants. Instead, Ifetayo Harvey opted for a morning on magic mushrooms.Mar 7, 2021Mar 7, 2021
Akash PasrichainWest DoseWho Gets to Give? The Debate Around Credentialing Psilocybin Clinicians.While the scientific community questions who is fit to receive psilocybin services, there is just as much uncertainty around who is fit to…Jan 29, 2021Jan 29, 2021
Akash PasrichainWest DoseA Primer on Psychedelic Drugs, Around America and in OregonWhen it comes to drug deregulation, Oregon has a habit of going first.Jan 15, 2021Jan 15, 2021
Akash PasrichainWest DoseAbout the AuthorAkash Pasricha is an M.S. Candidate at Columbia University’s Graduate School of Journalism. He is focused on business journalism, pursuing…Jan 13, 2021Jan 13, 2021